Related references
Note: Only part of the references are listed.Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study
Laura Michiels et al.
NEUROIMAGE (2021)
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi et al.
NATURE COMMUNICATIONS (2020)
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
Adam P. Mecca et al.
ALZHEIMERS & DEMENTIA (2020)
Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
Michel Koole et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
Sjoerd J. Finnema et al.
EPILEPSIA (2019)
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
Kerstin Heurling et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Lower synaptic density is associated with depression severity and network alterations
Sophie E. Holmes et al.
NATURE COMMUNICATIONS (2019)
Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
Sjoerd J. Finnema et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
Ming-Kai Chen et al.
JAMA NEUROLOGY (2018)
Default Mode Network Complexity and Cognitive Decline in Mild Alzheimer's Disease
Matthias Grieder et al.
FRONTIERS IN NEUROSCIENCE (2018)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Loescher et al.
CNS DRUGS (2016)
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
Nabeel B. Nabulsi et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Brivaracetam augments short-term depression and slows vesicle recycling
Xiaofeng Yang et al.
EPILEPSIA (2015)
Imaging the default mode network in aging and dementia
Anne Hafkemeijer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Conn: A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Susan Whitfield-Gabrieli et al.
BRAIN CONNECTIVITY (2012)
Cotrafficking of SV2 and Synaptotagmin at the Synapse
Jia Yao et al.
JOURNAL OF NEUROSCIENCE (2010)
SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
Wen-Pin Chang et al.
JOURNAL OF NEUROSCIENCE (2009)
Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission
Xiao-Feng Yang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2009)
The brain's default network - Anatomy, function, and relevance to disease
Randy L. Buckner et al.
YEAR IN COGNITIVE NEUROSCIENCE 2008 (2008)
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
A. Matagne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Self-projection and the brain
Randy L. Buckner et al.
TRENDS IN COGNITIVE SCIENCES (2007)
Synaptic vesicle protein 2 enhances release probability at quiescent synapses
KL Custer et al.
JOURNAL OF NEUROSCIENCE (2006)
SV2A and SV2C contain a unique synaptotagmin-binding site
AE Schivell et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
MD Greicius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional deactivations: Change with age and dementia of the Alzheimer type
C Lustig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
SV2 modulates the size of the readily releasable pool of secretory vesicles
T Xu et al.
NATURE CELL BIOLOGY (2001)
Share Paper
